Evidence map›Paper›PMID 26843520›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2016

Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.

Jessica Chubak, Michael P Garcia, Andrea N Burnett-Hartman, Yingye Zheng, Douglas A Corley, Ethan A Halm, Amit G Singal, Carrie N Klabunde, Chyke A Doubeni, Aruna Kamineni and 6 more

Abstract readMulticenter Study
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 4 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 4 syntheses or guidelines pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Second-generation capsule endoscopy for the detection of colorectal polyps: An updated systematic review and comparative meta-analysis of prospective studies.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Jessica ChubakGroup Health Research Institute, Seattle, Washington. chubak.j@ghc.org.
Michael P GarciaFred Hutchinson Cancer Research Center, Seattle, Washington.
Andrea N Burnett-HartmanFred Hutchinson Cancer Research Center, Seattle, Washington. Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado.
Yingye ZhengFred Hutchinson Cancer Research Center, Seattle, Washington.
Douglas A CorleyKaiser Permanente Northern California, Oakland, California.
Ethan A HalmDepartments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
Amit G SingalDepartments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
Carrie N KlabundeOffice of the Director, NIH, Rockville, Maryland.
Chyke A DoubeniDepartment of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Aruna KamineniGroup Health Research Institute, Seattle, Washington.
Theodore R LevinKaiser Permanente Medical Center, Walnut Creek, California.
Joanne E SchottingerKaiser Permanente Southern California, Pasadena, California.
Beverly B GreenGroup Health Research Institute, Seattle, Washington.
Virginia P QuinnKaiser Permanente Southern California, Pasadena, California.
Carolyn M RutterRAND Corporation, Santa Monica, California.
PROSPR consortium
Fred Hutch Cancer Center · USKaiser Permanente · USKaiser Permanente Center for Health Research · US

Funding

UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
Institute of Translational Health SciencesKL2TR000421 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$12.6M
Optimizing the use of colonoscopy for CRC screening in a large community-basedU54CA163262 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CORLEY, DOUGLAS ALLEN, DOUBENI, CHYKE ABADAMA · 2011 to 2017
$9.6M
Parkland-UT Southwestern PROSPR Center Colon Cancer Screening in a Safety netU54CA163308 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI SKINNER, CELETTE SUGG · 2011 to 2017
$8.0M
PROSPR Statistical Coordinating Center (PSCC)U01CA163304 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BARLOW, WILLIAM E, THORNQUIST, MARK · 2011 to 2017
$7.5M
Studying Colorectal Cancer Effectiveness of Screening Strategies (SuCCESS)U54CA163261 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CHUBAK, JESSICA · 2011 to 2017
$7.3M
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1KL2TR001103 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$4.0M
NCATS NIH HHS KL2 TR000421NCATS NIH HHS KL2 TR001103NCATS NIH HHS UL1 TR001105NCI NIH HHS U01 CA163304NCI NIH HHS U01CA163304NCI NIH HHS U54 CA163261NCI NIH HHS U54CA163261NCI NIH HHS U54 CA163262NCI NIH HHS U54CA163262NCI NIH HHS U54 CA163308NCI NIH HHS U54CA163308
6 · The paper itself

Abstract

backgroundTo reduce colorectal cancer mortality, positive fecal blood tests must be followed by colonoscopy.

methodsWe identified 62,384 individuals ages 50 to 89 years with a positive fecal blood test between January 1, 2011 and December 31, 2012 in four health care systems within the Population-Based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium. We estimated the probability of follow-up colonoscopy and 95% confidence intervals (CI) using the Kaplan-Meier method. Overall differences in cumulative incidence of follow-up across health care systems were assessed with the log-rank test. HRs and 95% CIs were estimated from multivariate Cox proportional hazards models.

resultsMost patients who received a colonoscopy did so within 6 months of their positive fecal blood test, although follow-up rates varied across health care systems (P <0.001). Median days to colonoscopy ranged from 41 (95% CI, 40-41) to 174 (95% CI, 123-343); percent followed-up by 12 months ranged from 58.1% (95% CI, 51.6%-63.7%) to 83.8% (95% CI, 83.4%-84.3%) and differences across health care systems were also observed at 1, 2, 3, and 6 months. Increasing age and comorbidity score were associated with lower follow-up rates.

conclusionIndividual characteristics and health care system were associated with colonoscopy after positive fecal blood tests. Patterns were consistent across health care systems, but proportions of patients receiving follow-up varied. These findings suggest that there is room to improve follow-up of positive colorectal cancer screening tests. IMPACT: Understanding the timing of colonoscopy after positive fecal blood tests and characteristics associated with lack of follow-up may inform future efforts to improve follow-up.

Indexed as

AgedAged, 80 and overColonoscopyFecesHumansMass ScreeningMiddle AgedOccult BloodRisk FactorsTime FactorsUnited States

Identifiers

PMID26843520
PMCPMC4767632
OpenAlexW2261378588

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.